Bioleap
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Bioleap operates in Healthcare & Life Sciences and is based in Cambridge. It was founded in 2022.
Bioleap is a biotechnology company that develops an AI-powered, physics-first biosimulation platform to accelerate drug discovery and the development of complex biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioleap Comparables
Compare Bioleap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Netabolics | 87% | |
| VeriSIM Life | 82% | |
| InSysBio | 79% |
For institutional investors. Book with your work email.
Bioleap Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 47% MoM.
- Jul 25, 2026
Monthly visitors grew 205% MoM, reaching 999.
For institutional investors. Book with your work email.
Bioleap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioleap's valuation, stock price, and market status.
Is Bioleap a public or private company?
Bioleap is a private company.
What is the current stock price of Bioleap?
Bioleap is a private company, so its shares have no public market price. Caplight tracks Bioleap's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioleap worth (valuation)?
Valuation information for Bioleap is not publicly available.
Can I buy Bioleap stock?
Bioleap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioleap's last funding round?
Funding round information for Bioleap is not publicly available.
Who are the main investors in Bioleap?
Investor information for Bioleap is not publicly disclosed.
Will Bioleap IPO soon?
No public IPO plans have been announced for Bioleap.
How can I track Bioleap secondary market activity?
Caplight tracks bids, offers, and trades in Bioleap's shares on secondary markets.